Health

Cardiovascular Logistics and Cardiology Consultants of Philadelphia Announce Partnership to Expand Access to Cardiovascular Care in Southeastern Pennsylvania
Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
Johnson & Johnson MedTech Announces Completion of First Cases with OTTAVA™ Robotic Surgical System
THORNE LAUNCHES ON-THE-GO SPORTS PERFORMANCE PRODUCT LINE VIA NEW CAMPAIGN WITH TENNIS STAR BEN SHELTON
Assisting Hands Home Care Expands Services in Frederick and Surrounding Counties
Cutting Edge At-Home MedTech and Digital Health Companies, Satio and Nanowear, to Collaborate on Accelerating Non-invasive Biomarkers, Diagnostics and Drug Delivery, Beyond the Remote Monitoring and Digital Assessment Tools Used Today
Curaleaf Launches Anthem, a Classic Pre-Roll Brand Celebrating American Grown Cannabis
Positive Outcome in 75% of CTCL Patients Treated with HyBryte™ for 18 Weeks
Clinical Study Shows USANA Celavive's Resurfacing Serum to Improve Appearance of Skin in Just Two Weeks
Karmanos Cancer Institute Highlights Symptoms to Not Ignore During Head and Neck Cancer Awareness Month
Palatin Appeals NYSE American Notice of Delisting
Sidekick Health entschlüsselt den Code der Therapietreue - für bessere Ergebnisse und niedrigere Kosten
Viome Launches AI-Powered Full Body Intelligence™ Test To Help You Stay Healthy, Slow Aging, and Make Illness Optional
CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America
Sidekick Health descifra el código de la adherencia a la medicación: mejores resultados y menores costes
Sidekick Health Cracks the Code on Medication Adherence -- Driving Better Outcomes and Lower Costs
hyperCORE Welcomes Atlas Clinical Research, Strengthening North American Partner Site Network
Great HealthWorks Earns 2025 Great Place to Work Certification™
IDEAYA Biosciences Announces Successful FDA Type D Meeting on Phase 3 Registrational Trial Design for Darovasertib as Neoadjuvant Therapy for Primary Uveal Melanoma
Chromatin Bioscience unterzeichnet Kollaborationsvertrag mit Astellas